Literature DB >> 19710276

International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital.

Jaroslav Hrabák1, Joanna Empel, Tamara Bergerová, Karel Fajfrlík, Pavla Urbásková, Izabela Kern-Zdanowicz, Waleria Hryniewicz, Marek Gniadkowski.   

Abstract

A 2-month survey of extended-spectrum beta-lactamase (ESBL) producers was performed in a Czech hospital. Klebsiella pneumoniae produced SHV-2, -5, or -12, Escherichia coli produced CTX-M-9 or -15, and other species produced TEM-92 or -132. All K. pneumoniae and E. coli isolates belonged to sequence types (STs) or clonal complexes (CCs) spread across the world (K. pneumoniae clonal complex 11 [CC11], CC14, and sequence type 101 [ST101] and E. coli CC31, CC73, CC131, and CC405) and carried various plasmids (mainly with A/C- and FII-type replicons).

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19710276      PMCID： PMC2756902          DOI： 10.1128/JCM.00901-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  46 in total

1.  Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.

Authors:  Aroonwadee Chanawong; Fatima Hannachi M'Zali; John Heritage; Jian-Hui Xiong; Peter Michael Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene.

Authors:  Laurent Poirel; Jean-Winoc Decousser; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection.

Authors:  S Takeshita; M Sato; M Toba; W Masahashi; T Hashimoto-Gotoh
Journal:  Gene       Date:  1987       Impact factor: 3.688

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.

Authors:  M Gniadkowski; I Schneider; R Jungwirth; W Hryniewicz; A Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

6.  A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.

Authors:  A Bauernfeind; H Grimm; S Schweighart
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

7.  Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.

Authors:  Andrea Endimiani; Francesco Luzzaro; Gioconda Brigante; Mariagrazia Perilli; Gianluigi Lombardi; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Toniolo
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.

Authors:  David A Boyd; Shaun Tyler; Sara Christianson; Allison McGeer; Matthew P Muller; Barbara M Willey; Elizabeth Bryce; Michael Gardam; Patrice Nordmann; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis.

Authors:  M J Struelens; F Rost; A Deplano; A Maas; V Schwam; E Serruys; M Cremer
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

10.  Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.

Authors:  Johann D D Pitout; Daniel B Gregson; Lorraine Campbell; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191
View more
  21 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.

Authors:  Amos Adler; Svetlana Paikin; Yelena Sterlin; Josef Glick; Rotem Edgar; Rima Aronov; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

3.  Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.

Authors:  Ivana Jamborova; Monika Dolejska; Jiri Vojtech; Sebastian Guenther; Raluca Uricariu; Joanna Drozdowska; Ivo Papousek; Katerina Pasekova; Wlodzimierz Meissner; Jozef Hordowski; Alois Cizek; Ivan Literak
Journal:  Appl Environ Microbiol       Date:  2014-11-07       Impact factor: 4.792

4.  Characterization of a P1-like bacteriophage carrying an SHV-2 extended-spectrum β-lactamase from an Escherichia coli strain.

Authors:  Typhaine Billard-Pomares; Stéphanie Fouteau; Marie Elise Jacquet; David Roche; Valérie Barbe; Miguel Castellanos; Jean Yves Bouet; Stéphane Cruveiller; Claudine Médigue; Jorge Blanco; Olivier Clermont; Erick Denamur; Catherine Branger
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

5.  Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010).

Authors:  Angela Novais; João Pires; Helena Ferreira; Luísa Costa; Carolina Montenegro; Claudia Vuotto; Gianfranco Donelli; Teresa M Coque; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

6.  Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases.

Authors:  Marco Maria D'Andrea; Claudia Venturelli; Tommaso Giani; Fabio Arena; Viola Conte; Paola Bresciani; Fabio Rumpianesi; Annalisa Pantosti; Franco Narni; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

7.  Molecular epidemiology of extended-spectrum beta-lactamase-producing extra-intestinal pathogenic Escherichia coli strains over a 2-year period (2017-2019) from Zimbabwe.

Authors:  Faustinos Tatenda Takawira; Johann Dd Pitout; Gaetän Thilliez; Tapfumanei Mashe; Ana Victoria Gutierrez; Robert A Kingsley; Gisele Peirano; Jorge Matheu; Stanley M Midzi; Lusubilo W Mwamakamba; David L Gally; Andrew Tarupiwa; Leckson Mukavhi; Marthie M Ehlers; Sekesai Mtapuri-Zinyowera; Marleen M Kock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-11-15       Impact factor: 3.267

8.  Comparative population analysis of Klebsiella pneumoniae strains with extended-spectrum β-lactamases colonizing patients in rehabilitation centers in four countries.

Authors:  A Baraniak; R Izdebski; J Fiett; E Sadowy; A Adler; M Kazma; J Salomon; C Lawrence; A Rossini; A Salvia; J Vidal Samso; J Fierro; M Paul; Y Lerman; S Malhotra-Kumar; C Lammens; H Goossens; W Hryniewicz; C Brun-Buisson; Y Carmeli; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

9.  Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution?

Authors:  Sebastian Guenther; Christa Ewers; Lothar H Wieler
Journal:  Front Microbiol       Date:  2011-12-19       Impact factor: 5.640

10.  Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.

Authors:  Monika Marejková; Květa Bláhová; Jan Janda; Angelika Fruth; Petr Petráš
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.